vs
Side-by-side financial comparison of Astrana Health, Inc. (ASTH) and OLYMPIC STEEL INC (ZEUS). Click either name above to swap in a different company.
Astrana Health, Inc. is the larger business by last-quarter revenue ($950.5M vs $490.7M, roughly 1.9× OLYMPIC STEEL INC). Astrana Health, Inc. runs the higher net margin — 0.7% vs 0.4%, a 0.3% gap on every dollar of revenue. On growth, Astrana Health, Inc. posted the faster year-over-year revenue change (42.9% vs 4.4%). Astrana Health, Inc. produced more free cash flow last quarter ($-6.0M vs $-12.9M). Over the past eight quarters, Astrana Health, Inc.'s revenue compounded faster (53.3% CAGR vs 0.1%).
Astrana Health, Inc. is a U.S.-based value-based healthcare services provider that primarily serves Medicare-eligible senior populations across the United States. It offers in-home primary care, chronic disease management, and care coordination services, aiming to improve patient health outcomes and reduce unnecessary medical costs.
Olympic Steel, Inc. is a metals service center based in Cleveland, Ohio. The company processes and distributes carbon, coated and stainless flat-rolled sheet, coil and plate steel, aluminium alloy, tin plate, and metal-intensive branded products primarily in the United States. Metals processing and value added services include tempering, stretch leveling, cutting-to-length, slitting, edging, shearing, blanking, burning, forming, shot blasting, laser punching, plate rolling, fabricating, machi...
ASTH vs ZEUS — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $950.5M | $490.7M |
| Net Profit | $6.6M | $2.2M |
| Gross Margin | — | — |
| Operating Margin | 1.9% | 1.5% |
| Net Margin | 0.7% | 0.4% |
| Revenue YoY | 42.9% | 4.4% |
| Net Profit YoY | 184.4% | -21.2% |
| EPS (diluted) | $0.12 | $0.18 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $950.5M | — | ||
| Q3 25 | $956.0M | $490.7M | ||
| Q2 25 | $654.8M | $496.5M | ||
| Q1 25 | $620.4M | $492.9M | ||
| Q4 24 | $665.2M | $418.8M | ||
| Q3 24 | $478.7M | $470.0M | ||
| Q2 24 | $486.3M | $526.3M | ||
| Q1 24 | $404.4M | $526.6M |
| Q4 25 | $6.6M | — | ||
| Q3 25 | $373.0K | $2.2M | ||
| Q2 25 | $9.4M | $5.2M | ||
| Q1 25 | $6.7M | $2.5M | ||
| Q4 24 | $-7.8M | $3.9M | ||
| Q3 24 | $16.1M | $2.7M | ||
| Q2 24 | $19.2M | $7.7M | ||
| Q1 24 | $14.8M | $8.7M |
| Q4 25 | 1.9% | — | ||
| Q3 25 | 2.0% | 1.5% | ||
| Q2 25 | 3.1% | 2.3% | ||
| Q1 25 | 3.3% | 1.6% | ||
| Q4 24 | 0.1% | 2.1% | ||
| Q3 24 | 5.9% | 1.7% | ||
| Q2 24 | 6.2% | 2.9% | ||
| Q1 24 | 7.5% | 3.0% |
| Q4 25 | 0.7% | — | ||
| Q3 25 | 0.0% | 0.4% | ||
| Q2 25 | 1.4% | 1.1% | ||
| Q1 25 | 1.1% | 0.5% | ||
| Q4 24 | -1.2% | 0.9% | ||
| Q3 24 | 3.4% | 0.6% | ||
| Q2 24 | 3.9% | 1.5% | ||
| Q1 24 | 3.7% | 1.7% |
| Q4 25 | $0.12 | — | ||
| Q3 25 | $0.01 | $0.18 | ||
| Q2 25 | $0.19 | $0.45 | ||
| Q1 25 | $0.14 | $0.21 | ||
| Q4 24 | $-0.14 | $0.33 | ||
| Q3 24 | $0.33 | $0.23 | ||
| Q2 24 | $0.40 | $0.66 | ||
| Q1 24 | $0.31 | $0.75 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $429.5M | $7.5M |
| Total DebtLower is stronger | — | $240.9M |
| Stockholders' EquityBook value | $779.3M | $579.1M |
| Total Assets | $2.2B | $1.1B |
| Debt / EquityLower = less leverage | — | 0.42× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $429.5M | — | ||
| Q3 25 | $463.4M | $7.5M | ||
| Q2 25 | $342.1M | $14.8M | ||
| Q1 25 | $260.9M | $13.3M | ||
| Q4 24 | $290.8M | $11.9M | ||
| Q3 24 | $350.3M | $11.1M | ||
| Q2 24 | $327.7M | $9.4M | ||
| Q1 24 | $337.3M | $10.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | $240.9M | ||
| Q2 25 | — | $233.2M | ||
| Q1 25 | — | $235.4M | ||
| Q4 24 | — | $272.5M | ||
| Q3 24 | — | $197.3M | ||
| Q2 24 | — | $209.2M | ||
| Q1 24 | — | $196.8M |
| Q4 25 | $779.3M | — | ||
| Q3 25 | $775.5M | $579.1M | ||
| Q2 25 | $765.5M | $578.2M | ||
| Q1 25 | $745.4M | $574.2M | ||
| Q4 24 | $712.7M | $573.9M | ||
| Q3 24 | $704.6M | $570.6M | ||
| Q2 24 | $678.9M | $569.5M | ||
| Q1 24 | $653.5M | $563.0M |
| Q4 25 | $2.2B | — | ||
| Q3 25 | $2.2B | $1.1B | ||
| Q2 25 | $1.4B | $1.1B | ||
| Q1 25 | $1.3B | $1.1B | ||
| Q4 24 | $1.4B | $1.0B | ||
| Q3 24 | $1.3B | $1.0B | ||
| Q2 24 | $1.3B | $1.0B | ||
| Q1 24 | $1.2B | $1.0B |
| Q4 25 | — | — | ||
| Q3 25 | — | 0.42× | ||
| Q2 25 | — | 0.40× | ||
| Q1 25 | — | 0.41× | ||
| Q4 24 | — | 0.47× | ||
| Q3 24 | — | 0.35× | ||
| Q2 24 | — | 0.37× | ||
| Q1 24 | — | 0.35× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.9M | $-5.4M |
| Free Cash FlowOCF − Capex | $-6.0M | $-12.9M |
| FCF MarginFCF / Revenue | -0.6% | -2.6% |
| Capex IntensityCapex / Revenue | 0.3% | 1.5% |
| Cash ConversionOCF / Net Profit | -0.44× | -2.50× |
| TTM Free Cash FlowTrailing 4 quarters | $104.5M | $41.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.9M | — | ||
| Q3 25 | $10.0M | $-5.4M | ||
| Q2 25 | $90.9M | $15.5M | ||
| Q1 25 | $16.6M | $49.4M | ||
| Q4 24 | $-10.9M | $14.6M | ||
| Q3 24 | $34.0M | $24.6M | ||
| Q2 24 | $23.2M | $-2.9M | ||
| Q1 24 | $6.0M | $-2.6M |
| Q4 25 | $-6.0M | — | ||
| Q3 25 | $7.4M | $-12.9M | ||
| Q2 25 | $89.5M | $6.8M | ||
| Q1 25 | $13.6M | $40.6M | ||
| Q4 24 | $-13.5M | $7.4M | ||
| Q3 24 | $31.7M | $15.6M | ||
| Q2 24 | $20.4M | $-11.3M | ||
| Q1 24 | $5.6M | $-7.4M |
| Q4 25 | -0.6% | — | ||
| Q3 25 | 0.8% | -2.6% | ||
| Q2 25 | 13.7% | 1.4% | ||
| Q1 25 | 2.2% | 8.2% | ||
| Q4 24 | -2.0% | 1.8% | ||
| Q3 24 | 6.6% | 3.3% | ||
| Q2 24 | 4.2% | -2.2% | ||
| Q1 24 | 1.4% | -1.4% |
| Q4 25 | 0.3% | — | ||
| Q3 25 | 0.3% | 1.5% | ||
| Q2 25 | 0.2% | 1.7% | ||
| Q1 25 | 0.5% | 1.8% | ||
| Q4 24 | 0.4% | 1.7% | ||
| Q3 24 | 0.5% | 1.9% | ||
| Q2 24 | 0.6% | 1.6% | ||
| Q1 24 | 0.1% | 0.9% |
| Q4 25 | -0.44× | — | ||
| Q3 25 | 26.69× | -2.50× | ||
| Q2 25 | 9.65× | 2.96× | ||
| Q1 25 | 2.48× | 19.70× | ||
| Q4 24 | — | 3.75× | ||
| Q3 24 | 2.11× | 9.01× | ||
| Q2 24 | 1.21× | -0.38× | ||
| Q1 24 | 0.40× | -0.30× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
ZEUS
| Carbon Flat Products | $268.2M | 55% |
| Specialty Metals Flat Products | $140.9M | 29% |
| Tubular And Pipe Products | $81.6M | 17% |
